NCT06246266

Brief Summary

The purpose of this study is to examine the effectiveness of the Helfer Skin Tap Technique and the ShotBlocker Technique in reducing pain in babies receiving intramuscular vaccination.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Feb 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 7, 2024

Status Verified

January 1, 2024

Enrollment Period

8 months

First QC Date

January 30, 2024

Last Update Submit

January 30, 2024

Conditions

Keywords

infantıntramuscularvaccineHelfer Skin Tap TechniqueShotBlockerpain

Outcome Measures

Primary Outcomes (1)

  • Neonatal Infant Pain Scale = NIPS

    The Newborn-Infant Pain Scale, developed by Lawrence et al. (1993) to evaluate the physiological and behavioral responses of newborns to pain, was adapted into Turkish by Akdovan (1999). Scale; It consists of five behavioral and one physiological parts, including facial expression, crying, breathing pattern, arm and leg movements, and sleep-wake state. The crying part of the scale is given 0-1 and 2 points, and the other parts are given 0-1 point. The total score can range from 0 to 7, and a score higher than 3 indicates greater pain intensity.

    Immediately after vaccination, the baby's pain will be evaluated with the Newborn Infant Pain Scale (NIPS).

Study Arms (2)

Helfer Skin Tap Technique group

EXPERIMENTAL

Mechanical stimulation given with the Helfer Skin Tap technique during intramuscular vaccine administration will distract the baby's attention.

Procedure: Helfer Skin Tap Technique group

ShotBlocker Technique group

EXPERIMENTAL

During intramuscular vaccine administration to babies, the injection ShotBlocker Technique will be applied using the ShotBlocker tool (a tool with a "U" appearance, with blunt but not pointed protrusions).

Procedure: ShotBlocker Technique group

Interventions

During intramuscular vaccine administration, the muscle will be tapped with the palmar surface of the fingers of the other hand that is not used, with light rhythmic movements, counting for 1-15 seconds. Then, when the muscle is entered with the injection, it will continue to be hit with light rhythmic movements for 1-3 seconds. Thus, the muscle will relax and the fibers around the muscle will be stimulated. Mechanical stimulation given with the Helfer Skin Tap technique during intramuscular vaccine administration will distract the baby's attention.

Helfer Skin Tap Technique group

The protruding but not sharp surface on the ShotBlocker tool will be placed on the baby's skin before intramuscular vaccine administration. Injection will be applied to the middle part of this vehicle, which has a 'U' appearance. This tool, which does not cause any harm to the skin surface, will provide stimulation to the muscle fibers according to the Gate Control Theory related to pain.

ShotBlocker Technique group

Eligibility Criteria

Age2 Months - 4 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Born between 38 and 42 weeks of gestation,
  • Between 2 and 4 months old,
  • Applying to the family health center for KPA (Conjugated Pneumococcal Vaccine) application,
  • No congenital anomalies, birth asphyxia or any chronic disease

You may not qualify if:

  • Born prematurely or postmaturely
  • Not between 2 and 4 months old
  • Those who come to the family health center for the administration of other vaccines other than the KPA (Conjugated Pneumococcal Vaccine) application administered via IM route.
  • Those with congenital anomalies, birth asphyxia or any chronic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 7, 2024

Study Start

February 5, 2024

Primary Completion

September 30, 2024

Study Completion

December 31, 2024

Last Updated

February 7, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share